Modulation of subthalamic T-type Ca2+ channels remedies locomotor deficits in a rat model of Parkinson disease

Journal of Clinical Investigation

Volumn 121, Issue 8, 2011, Pages 3289-3305

  Tai, Chun Hwei ^a,b   Yang, Ya Chin ^c   Pan, Ming Kai ^a,b   Huang, Chen Syuan ^c   Kuo, Chung Chin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; DOPAMINE; EFONIDIPINE; MIBEFRADIL; NICKEL; NIFEDIPINE; NNC 55 0396; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOTOR DYSFUNCTION; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PALLIATIVE THERAPY; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

ANIMALS; BENZIMIDAZOLES; CADMIUM; CALCIUM; CALCIUM CHANNELS, T-TYPE; CYCLOPROPANES; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; MALE; MIBEFRADIL; MOVEMENT; NAPHTHALENES; NEURONS; NICKEL; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; PARKINSON DISEASE; RATS; RATS, WISTAR;

EID: 79960973258     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI46482     Document Type: Article

References (60)

1. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic"functions. Prog Brain Res. 1990;85:119-146.
2. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol. 2007;64(1):20-24. (Pubitemid 46072419)
3. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 1994;72(2):507-520. (Pubitemid 24273560)
4. Hollerman JR, Grace AA. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res. 1992;590(1-2):291-299.
5. Benazzouz A, Boraud T, Feger J, Burbaud P, Bioulac B, Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov Disord. 1996;11(6):627-632. (Pubitemid 26381931)
6. Hassani OK, Mouroux M, Feger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 1996;72(1):105-115. (Pubitemid 26092990)
7. Perier C, Agid Y, Hirsch EC, Feger J. Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion. Neuroreport. 2000;11(14):3275-3278.
8. Vila M, et al. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci. 2000;12(1):337-344. (Pubitemid 30068438)
9. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990;249(4975):1436-1438.
10. Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci. 1993;5(4):382-389. (Pubitemid 23108592)
11. Limousin P, et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord. 1995;10(5):672-674.
12. Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet. 1997;350(9092):1676. (Pubitemid 28036831)
13. Limousin P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998;339(16):1105-1111. (Pubitemid 28465758)
14. Hamani C, Neimat JS, Lozano AM. Deep brain stimulation and chemical neuromodulation: current use and perspectives for the future. Acta Neurochir. 2007;97(pt 2):127-133.
15. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009;8(1):67-81.
16. Bevan MD, Wilson CJ. Mechanisms underlying spontaneous oscillation and rhythmic firing in rat subthalamic neurons. J Neurosci. 1999;19(17):7617-7628. (Pubitemid 29404617)
17. Do MT, Bean BP. Subthreshold sodium currents and pacemaking of subthalamic neurons: modulation by slow inactivation. Neuron. 2003;39(1):109-120. (Pubitemid 36830952)
18. Beurrier C, Bioulac B, Hammond C. Slowly inactivating sodium current (I(NaP)) underlies singlespike activity in rat subthalamic neurons. J Neurophysiol. 2000;83(4):1951-1957. (Pubitemid 30198651)
19. Nakanishi H, Kita H, Kitai ST. Electrical membrane properties of rat subthalamic neurons in an in vitro slice preparation. Brain Res. 1987;437(1):35-44. (Pubitemid 18029686)
20. Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature. 1999;400(6745):677-682.
21. Bevan MD, Magill PJ, Hallworth NE, Bolam JP, Wilson CJ. Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABA-A IPSPs. J Neurophysiol. 2002;87(3):1348-1362. (Pubitemid 34670802)
22. Urbain N, Rentero N, Gervasoni D, Renaud B, Chouvet G. The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anestheticfree rat. J Neurosci. 2002;22(19):8665-8675. (Pubitemid 35387607)
23. Hallworth NE, Wilson CJ, Bevan MD. Apaminsensitive small conductance calcium-activated potassium channels, through their selective coupling to voltage-gated calcium channels, are critical determinants of the precision, pace, and pattern of action potential generation in rat subthalamic nucleus neurons in vitro. J Neurosci. 2003;23(20):7525-7542. (Pubitemid 37034069)
24. Baufreton J, et al. D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci. 2003;23(3):816.
25. Cragg S, Baufreton J, Xue Y, Bolam J, Bevan M. Synaptic release of dopamine in the subthalamic nucleus. Eur J Neurosci. 2004;20(7):1788-1802. (Pubitemid 39471572)
26. Bal T, von Krosigk M, McCormick DA. Synaptic and membrane mechanisms underlying synchronized oscillations in the ferret lateral geniculate nucleus in vitro. J Physiol. 1995;483(pt 3):641-663.
27. Beurrier C, Congar P, Bioulac B, Hammond C. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci. 1999;19(2):599.
28. 2+ channels in rat subthalamic nucleus neurons. J Neurophysiol. 2000;84(5):2630.
29. Lacinova L. Voltage-dependent calcium channels. Gen Physiol Biophys. 2005;24(suppl 1):1-78. (Pubitemid 41025303)
30. Perez-Reyes E. Molecular characterization of a novel family of low voltage-activated, T-type, calcium channels. J Bioenerg Biomembr. 1998;30(4):313-318. (Pubitemid 28436153)
31. Huguenard JR. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol. 1996;58:329-348. (Pubitemid 26106724)
32. Clozel JP, Ertel EA, Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl. 1997;15(5):S17-S25. (Pubitemid 28034980)
33. Lee JH, Gomora JC, Cribbs LL, Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H. Biophys J. 1999;77(6):3034-3042.
34. Monteil A, Chemin J, Bourinet E, Mennessier G, Lory P, Nargeot J. Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels. J Biol Chem. 2000;275(9):6090-6100. (Pubitemid 30129892)
35. Klugbauer N, Marais E, Lacinova L, Hofmann F. A T-type calcium channel from mouse brain. Pflugers Arch. 1999;437(5):710-715. (Pubitemid 29161927)
36. Magarinos-Ascone C, Pazo JH, Macadar O, Buno W. High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease. Neuroscience. 2002;115(4):1109-1117. (Pubitemid 35351701)
37. Huang L, et al. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl) propyl]-N-methylamino)ethyl)- 6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther. 2004;309(1):193-199. (Pubitemid 38393130)
38. Li M, Hansen JB, Huang L, Keyser BM, Taylor JT. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Cardiovasc Drug Rev. 2005;23(2):173-196. (Pubitemid 41278975)
39. Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil. Drug Metab Dispos. 2008;36(7):1291-1299. (Pubitemid 351929313)
40. Lacinova L, Klugbauer N, Hofmann F. Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers. Neuropharmacology. 2000;39(7):1254-1266. (Pubitemid 30173189)
41. 2+ channel cloned from human heart. Naunyn Schmiedebergs Arch Pharmacol. 2000;361(6):590-599.
42. Furukawa T, et al. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+channels. Br J Pharmacol. 2004;143(8):1050-1057. (Pubitemid 40065506)
43. 2+ channel blocker R(-) efonidipine. Naunyn Schmiedebergs Arch Pharmacol. 2008;377(4-6):411-421.
44. Lenz FA, Kwan HC, Martin RL, Tasker RR, Dostrovsky JO, Lenz YE. Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. Brain. 1994;117(pt 3):531-543.
45. Volkmann J, et al. Central motor loop oscillations in parkinsonian resting tremor revealed by magnetoencephalography. Neurology. 1996;46(5):1359-1370. (Pubitemid 26159299)
46. Hurtado JM, Gray CM, Tamas LB, Sigvardt KA. Dynamics of tremor-related oscillations in the human globus pallidus: a single case study. Proc Natl Acad Sci U S A. 1999;96(4):1674-1679. (Pubitemid 29098510)
47. Elble RJ. Origins of tremor. Lancet. 2000;355(9210):1113-1114. (Pubitemid 30172927)
48. Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A. The cerebral oscillatory network of parkinsonian resting tremor. Brain. 2003;126(pt 1):199-212. (Pubitemid 36068570)
49. Amtage F, et al. Tremor-correlated neuronal activity in the subthalamic nucleus of Parkinsonian patients. Neurosci Lett. 2008;442(3):195-199.
50. Reck C, et al. Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease. Eur J Neurosci. 2009;29(3):599-612.
51. Bergman H, Wichmann T, Karmon B, DeLong M. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 1994;72(2):507.
52. Alvarez L, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry. 2009;80(9):979-985.
53. Perez-Reyes E, et al. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature. 1998;391(6670):896-900. (Pubitemid 28157667)
54. 2+ channels in rat thalamic neurons. J Neurosci. 2001;21(6):1884-1892.
55. Carlson JD, Cleary DR, Cetas JS, Heinricher MM, Burchiel KJ. Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients. J Neurophysiol. 2010;103(2):962-967.
56. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology. 2000;55(12 suppl 6):S13-S16. (Pubitemid 32103937)
57. Nambu A. A new approach to understand the pathophysiology of Parkinson's disease. J Neurol. 2005;252(suppl 4):IV1-IV4. (Pubitemid 41437715)
58. Akaike N. [Physiology and pharmacology of calcium channel]. Nippon Seirigaku Zasshi. 1983;45(6):261-278.
59. Carbone E, Lux HD. Kinetics and selectivity of a low-voltage-activated calcium current in chick and rat sensory neurones. J Physiol. 1987;386:547-570. (Pubitemid 17059735)
60. Paxinoa G, Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. San Diego, California, USA: Academic Press; 1996.